HIGHLIGHTS
- who: Xin-Cheng Mao from the Harvard Medical School, United States Vrije University Brussel, Belgium have published the research work: Peripheral cytokine levels as novel predictors of survival in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- how: These studies were conducted in 11 countries. The statistical analysis of IL-6 and IL-8 was robust and adequate in the metaanalysis and the result showed that high levels of IL-6 and IL-8 were significantly associated with the prognosis of cancer patients treated with ICIs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.